Philina Lee - Net Worth and Insider Trading

Philina Lee Net Worth

The estimated net worth of Philina Lee is at least $3 Million dollars as of 2024-11-05. Philina Lee is the CHIEF COMMERCIAL OFFICER of Blueprint Medicines Corp and owns about 34,729 shares of Blueprint Medicines Corp (BPMC) stock worth over $3 Million. Details can be seen in Philina Lee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Philina Lee has not made any transactions after 2024-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Philina Lee

To

Philina Lee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Philina Lee owns 2 companies in total, including Blueprint Medicines Corp (BPMC) , and Fusion Pharmaceuticals Inc (FUSN) .

Click here to see the complete history of Philina Lee’s form 4 insider trades.

Insider Ownership Summary of Philina Lee

Ticker Comapny Transaction Date Type of Owner
BPMC Blueprint Medicines Corp 2024-08-05 Chief Commercial Officer
FUSN Fusion Pharmaceuticals Inc 2021-02-11 director

Philina Lee Latest Holdings Summary

Philina Lee currently owns a total of 1 stock. Philina Lee owns 34,729 shares of Blueprint Medicines Corp (BPMC) as of August 5, 2024, with a value of $3 Million.

Latest Holdings of Philina Lee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BPMC Blueprint Medicines Corp 2024-08-05 34,729 96.37 3,346,834

Holding Weightings of Philina Lee


Philina Lee Form 4 Trading Tracker

According to the SEC Form 4 filings, Philina Lee has made a total of 4 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 41,913 shares on August 5, 2024, which brought Philina Lee around $4 Million.

Insider Trading History of Philina Lee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Philina Lee Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Philina Lee Ownership Network

Ownership Network List of Philina Lee

No Data

Ownership Network Relation of Philina Lee

Insider Network Chart

Philina Lee Owned Company Details

What does Blueprint Medicines Corp do?

Who are the key executives at Blueprint Medicines Corp?

Philina Lee is the Chief Commercial Officer of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include President & R and D Fouad Namouni , director & CEO & President Jeffrey W. Albers , and Principal FAO Michael Landsittel .

Blueprint Medicines Corp (BPMC) Insider Trades Summary

Over the past 18 months, Philina Lee made 3 insider transaction in Blueprint Medicines Corp (BPMC) with a net sale of 52,870. Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .

In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.

Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Blueprint Medicines Corp Insider Transactions

No Available Data

Philina Lee Mailing Address

Above is the net worth, insider trading, and ownership report for Philina Lee. You might contact Philina Lee via mailing address: C/o Fusion Pharmaceuticals, Inc., 270 Longwood Road South, Hamilton D0 L8p Oa6.